David Francis Carroll - 21 Dec 2021 Form 4 Insider Report for IVERIC bio, Inc.

Role: SVP, CFO and Treasurer
Signature: /s/ Todd Anderman, as Attorney-in-Fact for David F. Carroll
Issuer symbol: N/A
Transactions as of: 21 Dec 2021
Net transactions value: -$898,334
Form type: 4
Filing time: 23 Dec 2021, 15:01:46 UTC
Previous filing: 21 Dec 2021
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Sale	$898,334	-56,207	-54%	$15.98	48,823	21 Dec 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2021.
F2	The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.50 to $16.15 per share on December 21, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.

Content

The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2021.

The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.50 to $16.15 per share on December 21, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.